These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination. Zhang Y; Li X; Ciric B; Curtis MT; Chen WJ; Rostami A; Zhang GX Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9082-9093. PubMed ID: 32253301 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis. Kerstetter AE; Padovani-Claudio DA; Bai L; Miller RH Exp Neurol; 2009 Nov; 220(1):44-56. PubMed ID: 19616545 [TBL] [Abstract][Full Text] [Related]
4. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects. Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441 [TBL] [Abstract][Full Text] [Related]
5. ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases. Pouzol L; Baumlin N; Sassi A; Tunis M; Marrie J; Vezzali E; Farine H; Mentzel U; Martinic MM FASEB J; 2021 Mar; 35(3):e21431. PubMed ID: 33595155 [TBL] [Abstract][Full Text] [Related]
6. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324 [TBL] [Abstract][Full Text] [Related]
7. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models. Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M Cells; 2021 Apr; 10(4):. PubMed ID: 33924474 [TBL] [Abstract][Full Text] [Related]
8. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221 [TBL] [Abstract][Full Text] [Related]
9. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis. Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811 [TBL] [Abstract][Full Text] [Related]
10. Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis. Seyedsadr MS; Weinmann O; Amorim A; Ineichen BV; Egger M; Mirnajafi-Zadeh J; Becher B; Javan M; Schwab ME Neurobiol Dis; 2019 Apr; 124():189-201. PubMed ID: 30468865 [TBL] [Abstract][Full Text] [Related]
11. Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway. Liu SQ; Zhang ML; Zhang HJ; Liu FZ; Chu RJ; Zhang GX; Zhu L Life Sci; 2017 Jul; 180():36-41. PubMed ID: 28499934 [TBL] [Abstract][Full Text] [Related]
12. miR-219 Cooperates with miR-338 in Myelination and Promotes Myelin Repair in the CNS. Wang H; Moyano AL; Ma Z; Deng Y; Lin Y; Zhao C; Zhang L; Jiang M; He X; Ma Z; Lu F; Xin M; Zhou W; Yoon SO; Bongarzone ER; Lu QR Dev Cell; 2017 Mar; 40(6):566-582.e5. PubMed ID: 28350989 [TBL] [Abstract][Full Text] [Related]
13. Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis. Nastasijevic B; Wright BR; Smestad J; Warrington AE; Rodriguez M; Maher LJ PLoS One; 2012; 7(6):e39595. PubMed ID: 22761835 [TBL] [Abstract][Full Text] [Related]
14. The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis. Cannella B; Hoban CJ; Gao YL; Garcia-Arenas R; Lawson D; Marchionni M; Gwynne D; Raine CS Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10100-5. PubMed ID: 9707607 [TBL] [Abstract][Full Text] [Related]
15. Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells. Liu L; Darnall L; Hu T; Choi K; Lane TE; Ransohoff RM J Neurosci; 2010 Jul; 30(27):9074-83. PubMed ID: 20610741 [TBL] [Abstract][Full Text] [Related]
16. Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis. Hooijmans CR; Hlavica M; Schuler FAF; Good N; Good A; Baumgartner L; Galeno G; Schneider MP; Jung T; de Vries R; Ineichen BV Sci Rep; 2019 Jan; 9(1):822. PubMed ID: 30696832 [TBL] [Abstract][Full Text] [Related]
17. Regulatory B Cells Normalize CNS Myeloid Cell Content in a Mouse Model of Multiple Sclerosis and Promote Oligodendrogenesis and Remyelination. Pennati A; Nylen EA; Duncan ID; Galipeau J J Neurosci; 2020 Jun; 40(26):5105-5115. PubMed ID: 32430295 [TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis. Kumar S; Patel R; Moore S; Crawford DK; Suwanna N; Mangiardi M; Tiwari-Woodruff SK Neurobiol Dis; 2013 Aug; 56():131-44. PubMed ID: 23603111 [TBL] [Abstract][Full Text] [Related]
19. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Merkler D; Ernsting T; Kerschensteiner M; Brück W; Stadelmann C Brain; 2006 Aug; 129(Pt 8):1972-83. PubMed ID: 16714315 [TBL] [Abstract][Full Text] [Related]
20. A regenerative approach to the treatment of multiple sclerosis. Deshmukh VA; Tardif V; Lyssiotis CA; Green CC; Kerman B; Kim HJ; Padmanabhan K; Swoboda JG; Ahmad I; Kondo T; Gage FH; Theofilopoulos AN; Lawson BR; Schultz PG; Lairson LL Nature; 2013 Oct; 502(7471):327-332. PubMed ID: 24107995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]